AEZS - COSCIENS Biopharma Inc.

5.31
5.310   100.000%

Share volume: 0
Last Updated: 08-08-2024

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-29.52%
1 Year
-51.82%
2 Year
-74.45%
Key data
Stock price
$5.31
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$3.80 - $11.10
52 WEEK CHANGE
-$57.57
MARKET CAP 
21.140 M
YIELD 
N/A
SHARES OUTSTANDING 
3.695 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Klaus Paulini
Region: US
Website: http://www.aezsinc.com/
Employees: 47
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

æterna zentaris inc. (tsx: aez, nasdaq: aezs) is a global biopharmaceutical company focused on endrocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. æterna zentaris inc. (tsx: aez, nasdaq: aezs) est une société biopharmaceutique internationale, spécialisée dans la découverte, le développement et la commercialisation de thérapies en endocrinologie et en oncologie.

Recent news